A human monoclonal anti-TNF alpha antibody (adalimumab) reduces airway inflammation and ameliorates lung histology in a murine model of acute asthma

Allergologia et Immunopathologia

Volumn 43, Issue 1, 2015, Pages 14-18

  Catal, F ^a   Mete, E ^a   Tayman, C ^a   Topal, E ^b   Albayrak, A ^c   Sert, H ^a  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Adalimumab; Anti TNF alpha; Antibody; Asthma; Cytokine; Inflammation; Murine; Ovalbumin

Indexed keywords

ADALIMUMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ALLERGEN; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHIOLE; BRONCHUS; CONTROLLED STUDY; FEMALE; HISTOLOGY; INFLAMMATORY CELL; LUNG; LUNG ALVEOLUS WALL; LUNG EDEMA; LUNG INJURY; LUNG PARENCHYMA; MOUSE; MUSCLE HYPERTROPHY; NONHUMAN; OVALBUMIN-INDUCED AIRWAY INFLAMMATION; RESPIRATORY TRACT INFLAMMATION; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; DISEASE MODEL; DRUG EFFECTS; HUMAN; IMMUNOLOGY; PATHOLOGY; RESPIRATORY HYPERSENSITIVITY;

ALLERGENS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; ASTHMA; CELL MOVEMENT; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LUNG; MICE; MICE, INBRED BALB C; OVALBUMIN; RESPIRATORY HYPERSENSITIVITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84921613925     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2013.11.002     Document Type: Article

References (24)

1. (GINA) 2011. Available from: http://www.ginasthma.org/.
2. Hogg J.C. Pathology of asthma. J Allergy Clin Immunol 1993, 92:1-5.
3. Lukacs N.W., Strieter R.M., Chensue S.W., Widmer M., Kunkel S.L. TNF-alpha mediates recruitment of neutrophils and eosinophils during airway inflammation. J Immunol 1995, 154:5411-5417.
4. Hybertson B.M., Jepson E.K., Cho O.J., Clarke J.H., Lee Y.M., Repine J.E. TNF mediates lung leak, but not neutrophil accumulation, in lungs of rats given IL-1 intratracheally. Am J Respir Crit Care Med 1997, 155:1972-1976.
5. Scheurich P., Thoma B., Ucer U., Pfizenmaier K. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNFalpha-mediated enhancement of T cell responses. J Immunol 1987, 138:1786-1790.
6. Casale T.B., Costa J.J., Galli S.J. TNF alpha is important in human lung allergic reactions. Am J Respir Cell Mol Biol 1996, 15:35-44.
7. Hutchison S., Choo-Kang B.S., Bundick R.V., Leishman A.J., Brewer J.M., McInnes I.B., et al. Tumour necrosis factor-alpha blockade suppresses murine allergic airways inflammation. Clin Exp Immunol 2008, 151:114-122.
8. Kim J., McKinley L., Natarajan S., Bolgos G.L., Siddiqui J., Copeland S., et al. Anti-tumor necrosis factor-alpha antibody treatment reduces pulmonary inflammation and methacholine hyper-responsiveness in a murine asthma model induced by house dust. Clin Exp Allergy 2006, 36:122-132.
9. Fisher C.E., Ahmad S.A., Fitch P.M., Lamb J.R., Howie S.E. FITC-induced murine pulmonary inflammation: CC10 up-regulation and concurrent Shh expression. Cell Biol Int 2005, 29:868-876.
10. Walker J.K., Fong A.M., Lawson B.L., Savov J.D., Patel D.D., Schwartz D.A., et al. Beta-arrestin-2 regulates the development of allergic asthma. J Clin Invest 2003, 112:566-574.
11. Teran L.M., Mochizuki M., Bartels J., Valencia E.L., Nakajima T., Hirai K., et al. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol 1999, 20:777-786.
12. Garcia-Zepeda E.A., Combadiere C., Rothenberg M.E., Sarafi M.N., Lavigne F., Hamid Q. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol 1996, 157:5613-5626.
13. Bradding P., Roberts J.A., Britten K.M., Sarafi M.N., Lavigne F., Hamid Q., et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the humanmast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994, 10:471-480.
14. Schwingshackl A., Duszyk M., Brown N., Moqbel R. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF alpha. J Allergy Clin Immunol 1999, 104:983-989.
15. Howarth P.H., Babu K.S., Arshad H.S., Lau L., Buckley M., McConnell W., et al. Tumour necrosis factor (TNF alpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 2005, 60:1012-1018.
16. Hanauer S.B., Sandborn W.J., Rutgeerts P., Fedorak R.N., Lukas M., MacIntosh D., et al. Human antitumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology 2006, 130:323-333.
17. Zuany-Amorim C., Haile S., Leduc D., Dumarey C., Huerre M., Vargaftig B.B. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest 1995, 95:2644-2651.
18. Renzetti L.M., Paciorek P.M., Tannu S.A., Dumarey C., Huerre M., Vargaftig B.B., et al. Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways. J Pharmacol Exp Ther 1996, 278:847-853.
19. Elliott M.J., Maini R.N., Feldmann M., Long-Fox A., Charles P., Katsikis P., et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 1993, 36:1681-1690.
20. Rudmann D.G., Moore M.W., Tepper J.S., Aldrich M.C., Pfeiffer J.W., Hogenesch H. Modulation of allergic inflammation in mice deficient in TNF receptors. Am J Physiol-Lung Cell Mol Physiol 2000, 279:1047-1057.
21. Hessel E.M., Van Oosterhout A.J., Van Ark I., Aldrich M.C., Pfeiffer J.W., Hogenesch H., et al. Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration. Am J Respir Cell Mol Biol 1997, 16:325-334.
22. Nam H.S., Lee S.Y., Kim S.J., Kim J.S., Kwon S.S., Kim Y.K., et al. The soluble tumor necrosis factor-alpha receptor suppresses airway inflammation in a murine model of acute asthma. Yonsei Med J 2009, 50:569-575.
23. Feldman M., Taylor P., Paleolog E., Brennan F.M., Maini R.N. Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases. Transplant Proc 1998, 30:4126-4127.
24. Berry M.A., Hargadon B., Shelley M., Parker D., Shaw D.E., Green R.H., et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006, 354:697-708.